NurOwn Cell Therapy Found Safe, Effective for Progressive MS in Phase 2 Trial April 1, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://multiplesclerosisnewstoday.com/news-posts/2021/03/26/nurown-cell-therapy-safe-effective-for-progressive-ms-phase-2-trial-top-line-results-show/ Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related
